Mustang Bio’s gene therapy has tremendous potential to cure XSCID or Bubble Boy Disease based on study results from St. Jude

episode

Cell Culture Dish Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Real Easy English: Talking about hard jobs 8 min · 18 Sep 2026 · Learning Easy English

The Truth About Mississippi's Education "Miracle" 54 min · 18 Sep 2026 · Plain English with Derek Thompson

Is AI too big to stop and do Europeans work less? 45 min · 18 Sep 2026 · Taking Stock

Tom Lee and Dan Ives Explain Everything 54 min · 18 Sep 2026 · The Compound and Friends

The Techno-Religion at the Center of the A.I. Debate 35 min · 18 Sep 2026 · The Daily

Report any issue

Source

Recorded31 Jul 2019

Publishercellculturedish.com ↗

Handlerec:14241964

Show notes

In this podcast, we interviewed Dr. Manny Litchman, President and CEO, Mustang Bio and Dr. Knut Niss, Chief Technology Officer, Mustang Bio about the exciting study results for their gene therapy candidate to treat X-SCID, why this disease is a good fit for gene therapy and next steps.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in